comparemela.com

Latest Breaking News On - அனாக்னி - Page 33 : comparemela.com

Leong: COVID-19 pandemic leads to epidemic of secrecy

Alpla set to invest €5 million in production of rPET packaging

ALPLA set to invest €5 million in production of rPET packaging 4 February 2021 Expand The ALPLA Group is investing more than €5 million in an extrusion system for food-grade recycled PET (rPET) made of used PET bottles at its site in Anagni, Italy. The site is home to one of the group’s most important preform production plants. The plant, which currently has a workforce of 91, processes around 50,000 tonnes of PET a year, of which currently only a very small proportion is recycled material. To this end, ALPLA is installing an extrusion system for 15,000 tonnes of rPET a year at the existing business premises, which is scheduled to go into operation in the second half of 2021. Ten new jobs will also be created.

BNP Paribas REIM Eurozone logistics fund adds Italian assets

2021-02-03T12:55:00+00:00 BNP Paribas Real Estate Investment Management (REIM), on behalf of its Eurozone Logistics Fund (ELF), has bought two fully-let logistic warehouses in Italy from Prologis. The manager said it has added a 30,750sqm warehouse in Anagni and a 27,300sqm warehouse in Brembate to ELF’s portfolio. Jean-Maxime Jouis, the global head of fund management at BNP Paribas REIM, said: “These two acquisitions help strengthen the European diversification of the fund, which is now composed of 12 new logistic platforms located in prime logistic areas. In addition, these assets are fully let to quality tenants.” Vincenzo Nocerino, CIO of BNP Paribas REIM Italy, said: “With these transactions, we have secured to ELF two properties of great value and return, expanding its exposure to the Italian logistic, which represents a strategic asset class for BNP Paribas REIM.”

AstraZeneca vaccine: EU regulators recommend authorization of Covid-19 shot

AstraZeneca vaccine: EU regulators recommend authorization of Covid-19 shot CNN 1/30/2021 By Laura Smith-Spark, Tara John and James Frater, CNN © Vincenzo Pinto/AFP/Getty Images A laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome, during the COVID-19 infection, caused by the novel coronavirus. - Catalent Biologics manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University of Oxfords Covid-19 vaccine candidate, AZD1222, providing large-scale vial filling and packaging to British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca.

AstraZeneca vaccine should not be given to people over 65, German health officials say

German officials say AstraZeneca vaccine shouldn t be given to over-65s, citing lack of data CNN 1/28/2021 By Claudia Otto, Laura Smith-Spark and Nadine Schmidt, CNN © Vincenzo Pinto/AFP/Getty Images A laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome, during the COVID-19 infection, caused by the novel coronavirus. - Catalent Biologics manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University of Oxfords Covid-19 vaccine candidate, AZD1222, providing large-scale vial filling and packaging to British-Swedish multinational pharmaceutical and biopharmaceutica

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.